1 January 2024 in Journal of Diabetes Research
Background: Tubulointerstitial injury plays a pivotal role in the progression of diabetic kidney disease (DKD), yet the link between neutrophil extracellular traps (NETs) and diabetic tubulointerstitial injury is still unclear.Methods: We analyzed microarray data (GSE30122) from the Gene Expression Omnibus (GEO) database to identify differentially expressed genes (DEGs) associated with DKD’s tubulointerstitial injury. Functional and pathway enrichment analyses were conducted to elucidate the involved biological processes (BP) and pathways. Weighted gene coexpression network analysis (WGCNA) identified modules associated with DKD. LASSO regression and random forest selected NET‐related characteristic genes (NRGs) related to DKD tubulointerstitial injury.Results: Eight hundred ninety‐eight DEGs were identified from the GSE30122 dataset. A significant module associated with diabetic tubulointerstitial injury overlapped with 15 NRGs. The hub genes, CASP1 and LYZ, were identified as potential biomarkers. Functional enrichment linked these genes with immune cell trafficking, metabolic alterations, and inflammatory responses. NRGs negatively correlated with glomerular filtration rate (GFR) in the Neph v5 database. Immunohistochemistry (IHC) validated increased NRGs in DKD tubulointerstitial injury.Conclusion: Our findings suggest that the CASP1 and LYZ genes may serve as potential diagnostic biomarkers for diabetic tubulointerstitial injury. Furthermore, NRGs involved in diabetic tubulointerstitial injury could emerge as prospective targets for the diagnosis and treatment of DKD.
1 January 2025 in Journal of Diabetes Research
Purpose: Chronic inflammation plays a key role in diabetic nephropathy (DN), yet the impact of tertiary lymphoid structures (TLSs) on disease progression remains poorly understood. This study explored the relationship between TLS maturity and renal outcomes in patients with DN. Methods: This study included 117 biopsy‐confirmed DN patients from the First Affiliated Hospital of Fujian Medical University. Patients were grouped based on TLS maturity, as determined by immunohistochemical staining. Clinical, laboratory, and pathological data were gathered, and Cox regression models were applied to assess renal outcome risk factors. Kaplan–Meier curves were constructed to compare renal survival among groups. A web‐based model integrating TLS maturity, urinary albumin‐to‐creatinine ratio (UACR), and renal pathology classification was developed. Results: Mature TLSs were associated with worse renal prognosis, with greater disease progression in the TLS+ group (75.4% vs. 53.3%, p = 0.006). Multivariate Cox regression analysis identified TLS maturity (HR = 1.819, 95% CI: 1.144–2.893, p = 0.011), DN glomerular classification (HR = 1.511, 95% CI: 1.057–2.160, p = 0.024), and UACR (HR = 1.121, 95% CI: 1.038–1.210, p = 0.004) as independent risk factors. The dynamic nomogram demonstrated strong predictive performance. Conclusions: TLS maturity independently predicts renal function decline in DN and may support personalized risk assessment through a web‐based model.
11 October 2026 in Journal of Cellular and Molecular Medicine
Minimal change disease (MCD) frequently relapses, and infection is one of the most common clinical triggers. Arachidonic acid (AA), an inflammatory lipid mediator released during tissue injury and infection, has been implicated in podocyte injury, but its contribution to metabolic dysfunction in MCD remains unclear. Here, we investigated whether AA aggravates PAN‐induced podocyte injury and examined the involvement of pyruvate kinase M2 (PKM2)‐associated metabolic dysfunction. In a puromycin aminonucleoside (PAN)‐induced rat model, AA exposure increased serum AA levels, aggravated proteinuria, reduced nephrin expression, promoted foot‐process effacement and exacerbated mitochondrial dysfunction. AA was also associated with reduced PKM1 and PKM2 abundance, increased PKM2 (Tyr105) phosphorylation, decreased pyruvate kinase activity and lower pyruvate, lactate and ATP levels. In cultured human podocytes, AA intensified PAN‐induced cytoskeletal disruption, mitochondrial dysfunction, oxidative stress and apoptosis. Pharmacological activation of PKM2 with TEPP‐46 partially restored PK‐associated metabolic activity, improved mitochondrial readouts and attenuated podocyte injury in vitro. These findings suggest that AA exacerbates PAN‐induced podocyte injury in association with PKM2‐associated metabolic dysfunction and mitochondrial stress.